本页面由Tiger Trade Technology Pte. Ltd.提供服务

Fulcrum Therapeutics

3.68
-0.0700-1.87%
盘后:3.680.00000.00%19:30 EDT
成交量:145.71万
成交额:538.70万
市值:2.81亿
市盈率:-3.04
高:3.75
开:3.75
低:3.68
收:3.75
52周最高:15.74
52周最低:2.83
股本:7,629.73万
流通股本:6,349.06万
量比:0.93
换手率:2.29%
股息:- -
股息率:- -
每股收益(TTM):-1.2104
每股收益(LYR):-1.1819
净资产收益率:-32.38%
总资产收益率:-19.59%
市净率:0.90
市盈率(LYR):-3.11

数据加载中...

2026/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/08/17

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/08/17

重要事件披露

Form 8-K - Current report
2026/08/17

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/08/03

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/29

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/17

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/25

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/25

重要事件披露

Form 8-K - Current report
2026/06/12

重要事件披露

Form 8-K - Current report